Motivational interviewing to promote interconception health: A scoping review of evidence from clinical trials.

Health behavior change Interconception health Motivational enhancement Motivational interviewing Postpartum care Preconception health Preventive health care

Journal

Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280

Informations de publication

Date de publication:
11 2022
Historique:
received: 07 03 2022
revised: 07 07 2022
accepted: 15 07 2022
pubmed: 24 7 2022
medline: 6 10 2022
entrez: 23 7 2022
Statut: ppublish

Résumé

Promoting interconception health can improve birth outcomes and long-term women's health. Motivational Interviewing (MI) is an evidence-based behavior change strategy that can address interconception health behaviors and health care engagement. This scoping review assessed the evidence for using MI to promote interconception health and assessed features of successful MI interventions. We searched PubMed, CHINAL, and Cochrane databases for clinical trials that involved an MI intervention and at least one comparison group published by 8/31/2021. Interventions occurred during pregnancy or within three months postpartum and outcomes were measured between birth and one year postpartum. We abstracted data on trial characteristics including outcome, population, interventionist training, MI fidelity monitoring, intervention dose, and comparison condition. We examined whether trials that demonstrated statistically significant improvement in outcomes had common features. There were 37 included studies. Interventions addressed breastfeeding, teen contraception, tobacco, alcohol, or substance use, vaccine acceptance, nutrition, physical activity, and depression. No trials addressed more than one topic. Nineteen studies demonstrated improved outcomes. Interventions during the perinatal or postnatal periods were more likely to demonstrate improved interconception outcomes than interventions in the prenatal period. No other trial characteristics were consistently associated with demonstrating improved outcomes. MI has been applied to a variety of interconception health behaviors, with some promising results, particularly for interventions in the perinatal or postpartum period. Outcomes were not clearly attributable to any other differences in intervention or study design. Further exploring context or implementation may help maximize the potential of MI in interconception health promotion. MI may be implemented across a range of clinical settings, patient groups, and time points around pregnancy. Interventions on health topics relevant to the interconception period should incorporate perinatal or postpartum components.

Sections du résumé

BACKGROUND
Promoting interconception health can improve birth outcomes and long-term women's health. Motivational Interviewing (MI) is an evidence-based behavior change strategy that can address interconception health behaviors and health care engagement.
OBJECTIVE
This scoping review assessed the evidence for using MI to promote interconception health and assessed features of successful MI interventions.
METHODS
We searched PubMed, CHINAL, and Cochrane databases for clinical trials that involved an MI intervention and at least one comparison group published by 8/31/2021. Interventions occurred during pregnancy or within three months postpartum and outcomes were measured between birth and one year postpartum. We abstracted data on trial characteristics including outcome, population, interventionist training, MI fidelity monitoring, intervention dose, and comparison condition. We examined whether trials that demonstrated statistically significant improvement in outcomes had common features.
RESULTS
There were 37 included studies. Interventions addressed breastfeeding, teen contraception, tobacco, alcohol, or substance use, vaccine acceptance, nutrition, physical activity, and depression. No trials addressed more than one topic. Nineteen studies demonstrated improved outcomes. Interventions during the perinatal or postnatal periods were more likely to demonstrate improved interconception outcomes than interventions in the prenatal period. No other trial characteristics were consistently associated with demonstrating improved outcomes.
DISCUSSION
MI has been applied to a variety of interconception health behaviors, with some promising results, particularly for interventions in the perinatal or postpartum period. Outcomes were not clearly attributable to any other differences in intervention or study design. Further exploring context or implementation may help maximize the potential of MI in interconception health promotion.
PRACTICAL VALUE
MI may be implemented across a range of clinical settings, patient groups, and time points around pregnancy. Interventions on health topics relevant to the interconception period should incorporate perinatal or postpartum components.

Identifiants

pubmed: 35870992
pii: S0738-3991(22)00333-0
doi: 10.1016/j.pec.2022.07.009
pmc: PMC9529865
mid: NIHMS1826188
pii:
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Pagination

3204-3212

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD102560
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Gregory, Ms. Maddox, Dr. Levine, Dr. Fiks, Dr. Lorch, and Dr. Resnicow have no competing interests to declare with regards to the manuscript Motivational Interviewing to promote interconception health: A scoping review of evidence from clinical trials.

Références

Acad Pediatr. 2015 May-Jun;15(3):311-8
pubmed: 25906700
Arch Womens Ment Health. 2019 Jun;22(3):315-325
pubmed: 30088145
Res Nurs Health. 2021 Apr;44(2):295-307
pubmed: 33598937
Patient Educ Couns. 2013 Nov;93(2):157-68
pubmed: 24001658
J Subst Abuse Treat. 2014 Jan;46(1):52-9
pubmed: 24051077
J Subst Abuse Treat. 2022 Jan;132:108419
pubmed: 34098201
Acad Pediatr. 2015 Nov-Dec;15(6):605-12
pubmed: 26210908
J Adv Nurs. 2020 Mar;76(3):888-902
pubmed: 31782535
Res Nurs Health. 2018 Jun;41(3):320-328
pubmed: 29906317
J Obstet Gynecol Neonatal Nurs. 2019 Jul;48(4):418-432
pubmed: 31181186
J Pediatr. 2020 Mar;218:35-41.e1
pubmed: 31870605
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2478-2487
pubmed: 29762737
Arch Psychiatr Nurs. 1998 Feb;12(1):12-20
pubmed: 9489170
Health Promot J Austr. 2012 Apr;23(1):5-9
pubmed: 22730940
Addict Behav. 2002 Mar-Apr;27(2):275-92
pubmed: 11817768
Lancet Public Health. 2017 Sep 05;2(9):e420-e437
pubmed: 28944313
Obstet Gynecol. 2018 Sep;132(3):784-785
pubmed: 30134408
Health Educ Res. 2003 Apr;18(2):156-70
pubmed: 12729175
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
J Clin Med. 2021 Apr 27;10(9):
pubmed: 33925502
Am J Public Health. 2017 Jan;107(1):55-57
pubmed: 27925833
PLoS One. 2018 Apr 13;13(4):e0195365
pubmed: 29652937
Health Expect. 2007 Mar;10(1):62-74
pubmed: 17324195
J Hum Lact. 2012 Aug;28(3):335-42
pubmed: 22584874
Acta Paediatr. 2015 Dec;104(467):96-113
pubmed: 26172878
Alcohol Clin Exp Res. 2008 Sep;32(9):1600-6
pubmed: 18627361
Psychooncology. 2006 Jan;15(1):9-19
pubmed: 15669023
Am J Prev Med. 2007 Mar;32(3):231-8
pubmed: 17236741
Child Obes. 2017 Apr;13(2):85-92
pubmed: 27854496
Nicotine Tob Res. 2015 Jan;17(1):48-57
pubmed: 25156527
Arch Womens Ment Health. 2017 Dec;20(6):791-801
pubmed: 28776105
Issues Compr Pediatr Nurs. 2015 Mar;38(1):7-21
pubmed: 25373565
Patient Educ Couns. 2015 Apr;98(4):499-505
pubmed: 25624118
Breastfeed Med. 2020 Aug;15(8):522-527
pubmed: 32559392
Obstet Gynecol. 2006 Jul;108(1):83-92
pubmed: 16816060
J Obstet Gynecol Neonatal Nurs. 2005 Nov-Dec;34(6):703-12
pubmed: 16282228
Drug Alcohol Depend. 2018 Apr 1;185:271-277
pubmed: 29482051
J Perinatol. 2013 Oct;33(10):811-6
pubmed: 23619375
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Int J Behav Nutr Phys Act. 2012 Mar 02;9:19
pubmed: 22385702
Ann Fam Med. 2009 Sep-Oct;7(5):436-45
pubmed: 19752472
J Am Coll Cardiol. 2011 Mar 22;57(12):1404-23
pubmed: 21388771
J Am Board Fam Med. 2018 Mar-Apr;31(2):201-210
pubmed: 29535236
J Womens Health (Larchmt). 2019 Sep;28(9):1246-1253
pubmed: 31259648
J Prim Care Community Health. 2013 Jan;4(1):31-5
pubmed: 23799687
Matern Child Health J. 2011 Nov;15(8):1217-27
pubmed: 20957514
Nicotine Tob Res. 2007 Jun;9(6):663-70
pubmed: 17558823
Addict Behav. 2009 Jan;34(1):1-8
pubmed: 18804331
BMC Public Health. 2018 Jun 28;18(1):811
pubmed: 29954370
Nicotine Tob Res. 2013 May;15(5):969-77
pubmed: 23109672
Health Educ Res. 2007 Oct;22(5):691-702
pubmed: 17138613
MMWR Morb Mortal Wkly Rep. 2016 Aug 19;65(32):826-30
pubmed: 27536925
Midwifery. 2013 Mar;29(3):240-5
pubmed: 22361008
Am J Obstet Gynecol. 2017 Oct;217(4):423.e1-423.e9
pubmed: 28619692

Auteurs

Emily F Gregory (EF)

Division of General Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, USA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia Research Institute, Philadelphia, USA. Electronic address: gregorye@chop.edu.

Adya I Maddox (AI)

Division of General Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, USA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia Research Institute, Philadelphia, USA.

Lisa D Levine (LD)

Maternal and Child Health Research Center, Department of Obstetrics and Gynecology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA.

Alexander G Fiks (AG)

Division of General Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, USA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia Research Institute, Philadelphia, USA.

Scott A Lorch (SA)

Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia Research Institute, Philadelphia, USA; Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia. Philadelphia, USA.

Kenneth Resnicow (K)

Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH